These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3018413)
1. Starvation-induced changes in rat brain corticotropin-releasing factor (CRF) and pituitary-adrenocortical response. Suemaru S; Hashimoto K; Hattori T; Inoue H; Kageyama J; Ota Z Life Sci; 1986 Sep; 39(13):1161-6. PubMed ID: 3018413 [TBL] [Abstract][Full Text] [Related]
2. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. Owens MJ; Edwards E; Nemeroff CB Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847 [TBL] [Abstract][Full Text] [Related]
3. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity. Suemaru S; Hashimoto K; Ota Z Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953 [TBL] [Abstract][Full Text] [Related]
4. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats. Wilson MA; Biscardi R; Smith MD; Wilson SP J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488 [TBL] [Abstract][Full Text] [Related]
5. Reduction in brain immunoreactive corticotropin-releasing factor (CRF) in spontaneously hypertensive rats. Hashimoto K; Hattori T; Murakami K; Suemaru S; Kawada Y; Kageyama J; Ota Z Life Sci; 1985 Feb; 36(7):643-7. PubMed ID: 3871498 [TBL] [Abstract][Full Text] [Related]
6. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. Rivier C; Vale W J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917 [TBL] [Abstract][Full Text] [Related]
7. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. Owens MJ; Knight DL; Ritchie JC; Nemeroff CB J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213 [TBL] [Abstract][Full Text] [Related]
8. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265 [TBL] [Abstract][Full Text] [Related]
9. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats. Garrido MM; Martin S; Ambrosio E; Fuentes JA; Manzanares J Neuroendocrinology; 1998 Aug; 68(2):116-22. PubMed ID: 9705578 [TBL] [Abstract][Full Text] [Related]
10. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. Owens MJ; Knight DL; Ritchie JC; Nemeroff CB J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212 [TBL] [Abstract][Full Text] [Related]
11. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats. Suemaru S; Hashimoto K; Ota Z Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111 [TBL] [Abstract][Full Text] [Related]
12. Dual effects of (D-Ala2,Met5)-enkephalinamide on CRF and ACTH secretion. Hashimoto K; Suemaru S; Ono N; Hattori T; Inoue H; Takao T; Sugawara M; Kageyama J; Ota Z Peptides; 1987; 8(1):113-8. PubMed ID: 3033617 [TBL] [Abstract][Full Text] [Related]
13. Characterization of central and peripheral components of the hypothalamus-pituitary-adrenal axis in the inbred Roman rat strains. Carrasco J; Márquez C; Nadal R; Tobeña A; Fernández-Teruel A; Armario A Psychoneuroendocrinology; 2008 May; 33(4):437-45. PubMed ID: 18276081 [TBL] [Abstract][Full Text] [Related]
14. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents. Pralong FP; Corder R; Gaillard RC Regul Pept; 1991 Feb; 32(2):217-26. PubMed ID: 1852030 [TBL] [Abstract][Full Text] [Related]
15. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779 [TBL] [Abstract][Full Text] [Related]
16. Adrenocortical response following acute neurogenic stimuli is mediated by CRF-41. Weidenfeld J; Rougeot C; Dray F; Feldman S Neurosci Lett; 1989 Dec; 107(1-3):189-94. PubMed ID: 2559367 [TBL] [Abstract][Full Text] [Related]
17. Constant light and dark affect the circadian rhythm of the hypothalamic-pituitary-adrenal axis. Fischman AJ; Kastin AJ; Graf MV; Moldow RL Neuroendocrinology; 1988 Apr; 47(4):309-16. PubMed ID: 2836747 [TBL] [Abstract][Full Text] [Related]
18. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883 [TBL] [Abstract][Full Text] [Related]
19. Brain corticotropin-releasing factor (CRF) and catecholamine responses in acutely stressed rats. Suemaru S; Hashimoto K; Ota Z Endocrinol Jpn; 1985 Oct; 32(5):709-18. PubMed ID: 3004928 [TBL] [Abstract][Full Text] [Related]
20. The effect of chronic exercise on the pituitary-adrenocortical response in conscious rats. Watanabe T; Morimoto A; Sakata Y; Wada M; Murakami N J Physiol; 1991 Aug; 439():691-9. PubMed ID: 1654420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]